Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants. - Wikidata - wikimedia - TriplyDB

Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants.

Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants.

http://www.wikidata.org/entity/Q33936087

about

Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants.Newer Oral Anticoagulants: Stroke Prevention and Pitfalls.Stroke Prevention in Atrial Fibrillation in the Very Elderly: Anticoagulant Therapy Is No Longer a Sin.Underuse of Anticoagulation in Older Patients with Atrial Fibrillation and CHADS2 Score ≥ 2: Are We Doing Better Since the Marketing of Direct Oral Anticoagulants?Role of rivaroxaban in the management of atrial fibrillation: insights from clinical practice.Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients.Predictors of new oral anticoagulant drug initiation as opposed to warfarin in elderly adults: a retrospective observational study in Southern Italy

P2860

Q37437878-3C72322A-1034-463D-A775-E74E7BFA7443 Q38878032-75A916F5-E162-43D6-98D9-B9A4F739C3FF Q42354433-A67DE1D8-621B-443D-9230-D0863F0082CA Q48098308-9F3FA094-ECA1-4646-AC63-E39BDCFB8D33 Q48508504-8F5FDB01-E0CA-4D45-AE9B-C3CDDBF98FE9 Q50191220-469649EA-6801-4565-BC2C-8ABEB1C0E07A Q57817732-6FB09D58-826A-4537-AE6A-CBA6A0D82DBB

P2860

Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants.

http://www.wikidata.org/entity/Q33936087

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Anticoagulation in Patients Ag ...... of Novel Oral Anticoagulants.

@ast

Anticoagulation in Patients Ag ...... of Novel Oral Anticoagulants.

@en

type

label

Anticoagulation in Patients Ag ...... of Novel Oral Anticoagulants.

@ast

Anticoagulation in Patients Ag ...... of Novel Oral Anticoagulants.

@en

prefLabel

Anticoagulation in Patients Ag ...... of Novel Oral Anticoagulants.

@ast

Anticoagulation in Patients Ag ...... of Novel Oral Anticoagulants.

@en

P1433

Q33936087-DFF33713-77CC-49FE-BAA8-42ED3C322F8C

P1476

Q33936087-5EDDC4F0-0AFC-491C-9076-911E1FFC9FE8

P2093

Q33936087-68EB1723-3D0A-4D7F-8B3E-38EC814109CE

Q33936087-C88E324C-F2B3-4D29-B218-8416BDA6134E

P2860

Q33936087-03AF63DF-ADF4-4F4B-98C6-954086A1D392

Q33936087-055FBDF5-B31C-4224-8568-264C6ABCA580

Q33936087-08B88162-3DE9-49EE-A3BC-871278A44558

Q33936087-101FE157-758A-4B8F-BA9A-ACF7DA232129

Q33936087-220D876D-7B6F-4538-9584-53038D62FC12

Q33936087-2961A233-E46B-4402-BDC4-44E55C1679DD

Q33936087-2C284DCE-FBD0-4E15-A832-89545E57210D

Q33936087-325DAD3F-4C92-4AFF-B61D-C92BFA8EB444

Q33936087-3975DFC3-39BA-4EAE-AC84-EFC552D437D9

Q33936087-397C3D62-E7F5-4A6F-B3B2-B4C8C7C92887

P2888

Q33936087-0788852D-77A4-4570-8B2A-EC0DA20DFE60

P304

Q33936087-6F44AB7F-F7B4-42A0-8EA2-560340BA2E7E

P31

Q33936087-340FBF18-F1FC-400C-B38D-92631837C8E8

P356

Q33936087-B2EBCB4B-4A9B-4424-892B-BEDC446EBB52

P433

Q33936087-FD831872-B97F-4FEC-B2F5-E0F715FD93D7

P478

Q33936087-0AF303C1-CD1B-4BB2-B33E-9C5FC627568D

P50

Q33936087-3992FB5E-7B7C-4B01-B2C9-F96E1B3207F5

P577

Q33936087-7C3350F4-06C4-489A-A11C-594CF88C6658

P5875

Q33936087-3E97C8AE-8B19-494E-AC8B-C6F512310DE9

P6179

Q33936087-4515F554-5A98-4766-BE4F-C954E68481C7

P698

Q33936087-CFB40B88-11AC-498C-921E-B5D6EE2ABB71

P921

Q33936087-88570555-96C1-4A35-A114-80E2FF236109

P932

Q33936087-94FB5227-0DB0-4B22-9593-19E9BB481E69

P356

S40119-013-0019-Y

P1433

Cardiology and therapy

P1476

Anticoagulation in Patients Ag ...... of Novel Oral Anticoagulants.

@en

P2093

Kuan H Ng

http://www.w3.org/2001/XMLSchema#string

Robert G Hart

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas

Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study

Atrial fibrillation in the elderly: facts and management

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis

Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation

Independent predictors of stroke in patients with atrial fibrillation: a systematic review

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

P2888

s40119-013-0019-y

P304

135-149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40119-013-0019-Y

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

John W. Eikelboom

P577

2013-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257809029

http://www.w3.org/2001/XMLSchema#string

P6179

1005998822

http://www.w3.org/2001/XMLSchema#string

P698

25135392

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

4107426

http://www.w3.org/2001/XMLSchema#string